Although infection by high-risk human papillomaviruses (HPV) has been proven a major determinant for cervical cancer [19, 20], whether the human immune mediators such as hBD3 also participate in the cervical carcinogenesis remains to be elucidated. The gene discussed is DEFB103A; the disease is cervical carcinoma.